We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.

Skip to main content

The Jackson Laboratory

Home

Recent Searches

Share this Post

Share on facebook
Share on twitter
Share on linkedin
Share on email

Home
Documents
Upcoming Release of iPSC Lines

Upcoming Release of iPSC Lines

Download PDF

Previous Flipbook

Aged HET3 Tech Sheet

HET3 mice (also called UM-HET3) are a well-established, genetically heterogeneous mouse model used by the NIA’s Interventions Testing Program to reduce strain-specific characteristics on outcomes.
Next Flipbook

SITC 2023 Comparison of Blinatumomab and Biosimilar CD19xCD3 BiTE responses in PBMC-Humanized Mice Used as a Preclinical Lymphoma Mouse Mode

Other content in this Stream

over 2 years ago
Preclinical Neurobiology Services Booklet

Read More
9 months ago
Analytical Validation of Digital Mouse Detection, Identification, and Activity in the Envision Platform

Read More
about 1 year ago
Applying Digital Measures to Assess Dose Effects of Neuroactive Compounds

Read More
8 months ago
Type 2 Diabetes and Obesity Drug Development

Read More
over 1 year ago
Accelerating Biologics Discovery and Development with JAX

Read More
5 months ago
PDX Models

Read More
over 1 year ago
Digital Measures in an Animal Model of Neuromotor Disease

Read More
over 1 year ago
Emerging Models for Alzheimer's Disease

Read More
11 months ago
HuPK™: A Humanized Platform for therapeutic antibody PK evaluation

Read More
almost 3 years ago
They're More than Mice They're J Mice

Read More
almost 3 years ago
JAX Resources for the Management of Transgenic Mice

Read More
over 2 years ago
Aged HET3 Tech Sheet

HET3 mice (also called UM-HET3) are a well-established, genetically heterogeneous mouse model used by the NIA’s Interventions Testing Program to reduce strain-specific characteristics on outcomes.

Read More
over 2 years ago
SITC 2023 Comparison of Blinatumomab and Biosimilar CD19xCD3 BiTE responses in PBMC-Humanized Mice Used as a Preclinical Lymphoma Mouse Mode

Read More
over 2 years ago
SITC 2023 PBMC Humanized Mouse Model with Clinical Relevance in Assessing the Safety Profile of 4-1BB Agonist, Urelumab, in 5 Donors

Read More
almost 3 years ago
PEGS EU 2023 - A Novel, Translational Platform to Assess the Efficacy and Toxicity of Bispecific Antibodies

Read More
almost 3 years ago
PEGS EU 2023 - Predicting the Clinical PK of Candidate Therapeutic Antibodies

Read More
almost 3 years ago
PEGS EU 2023 - Translational Humanized Models for Immunotherapy Drug Development

Read More
almost 3 years ago
CD34+ Hu-NSG-SGM3-IL15 Tech Sheet

Read More
almost 3 years ago
CD34+ Hu-NSG-FLT3 Tech Sheet

Read More
almost 3 years ago
2023 AALAS P403 Comparing tumor erosion rate following P16MC38 subcutaneous (SC) vs. mammary fat pad (MFP) injections

Read More

Return to Home